TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
TCL Archive ASCO, AACI Ask $1.3 Billion for NCI, Full Funding Of Center Core, Group Grants May 4, 1984